Generic, Branded Generic & Proprietary Medicinal Products - Group 17
A Contract Award Notice
by REGIONAL BUSINESS SERVICES ORGANISATION, PROCUREMENT AND LOGISTICS SERVICE
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- 10 year (est.)
- Value
- £42M
- Sector
- HEALTH
- Published
- 12 Jan 2026
- Delivery
- To 12 Jan 2036 (est.)
- Deadline
- n/a
Related Terms
Location
Belfast
Geochart for 2 buyers and 38 suppliers
2 buyers
38 suppliers
- Accord Barnstaple
- Amarox Harrow
- Aspire Pharma Petersfield
- Baxter Healthcare Thetford
- Bayer Reading
- Beaumont Pharma Burnley
- Biogen Idec Bristol
- Bowmed Ibisqus Wrexham
- Chiesi Cheadle
- Colonis Pharma London
- Day Lewis Medical Croydon
- Desitin Pharma Woking
- Esteve Pharmaceuticals Maidenhead
- Flexipharm Austrading St Albans
- Flynn Pharma Stevenage
- Focus Pharmaceuticals London
- Hameln Pharma Gloucester
- Infectopharm Marlow
- Kent Pharma Ashford
- Kyowa Kirin International UK New Galashiels
- Lupin Healthcare Slough
- Macarthys Laboratories Romford
- Mercury Pharmaceuticals London
- Morningside Pharmaceuticals Loughborough
- Napp Pharmaceuticals Cambridge
- Novartis Pharmaceuticals Camberley
- Pfizer Sandwich
- Recordati Pharmaceuticals Hemel Hempstead
- Rosemont Pharmaceuticals Leeds
- Sandoz Camberley
- Stirling Anglian Pharmaceuticals Glasgow
- Sun Pharma Uxbridge
- Takeda Bucks
- Techdow Pharma England Guildford
- Teva Castlefford
- Thornton & Ross Huddersfield
- Viatris UK Healthcare Potters Bar
- Zentiva Pharma Guildford
Description
Generic, Branded Generic & Proprietary Medicinal Products - Group 17 (6067696)
Total Quantity or Scope
Seventeenth group tender for Generic, Branded Generic & Proprietary Medicinal Products
Award Detail
| 1 | Accord (Barnstaple)
|
| 2 | Amarox (Harrow)
|
| 3 | Aspire Pharma (Petersfield)
|
| 4 | Baxter Healthcare (Thetford)
|
| 5 | Bayer (Reading)
|
| 6 | Beaumont Pharma (Burnley)
|
| 7 | Biogen Idec (Bristol)
|
| 8 | Bowmed Ibisqus (Wrexham)
|
| 9 | Chiesi (Cheadle)
|
| 10 | Colonis Pharma (London)
|
| 11 | Day Lewis Medical (Croydon)
|
| 12 | Desitin Pharma (Woking)
|
| 13 | Esteve Pharmaceuticals (Maidenhead)
|
| 14 | Flexipharm Austrading (St Albans)
|
| 15 | Flynn Pharma (Stevenage)
|
| 16 | Focus Pharmaceuticals (London)
|
| 17 | Hameln Pharma (Gloucester)
|
| 18 | Infectopharm (Marlow)
|
| 19 | Kent Pharma (Ashford)
|
| 20 | Kyowa Kirin International UK New (Galashiels)
|
| 21 | Lupin Healthcare (Slough)
|
| 22 | Macarthys Laboratories (Romford)
|
| 23 | Mercury Pharmaceuticals (London)
|
| 24 | Morningside Pharmaceuticals (Loughborough)
|
| 25 | Napp Pharmaceuticals (Cambridge)
|
| 26 | Novartis Pharmaceuticals (Camberley)
|
| 27 | Pfizer (Sandwich)
|
| 28 | Recordati Pharmaceuticals (Hemel Hempstead)
|
| 29 | Rosemont Pharmaceuticals (Leeds)
|
| 30 | Sandoz (Camberley)
|
| 31 | Stirling Anglian Pharmaceuticals (Glasgow)
|
| 32 | Sun Pharma (Uxbridge)
|
| 33 | Takeda (Bucks)
|
| 34 | Techdow Pharma England (Guildford)
|
| 35 | Teva (Castlefford)
|
| 36 | Thornton & Ross (Huddersfield)
|
| 37 | Viatris UK Healthcare (Potters Bar)
|
| 38 | Zentiva Pharma (Guildford)
|
Award Criteria
| Award Criteria (Eligibility Envelope): Compliance with Contract Scope and Specification | _ |
| Award Criteria (Eligibility Envelope): Supply and Delivery of Product (i) (Evidence of Compliance with Good Distribution Practice (GDP) Requirements, as outlined in the Contract Scope and Specification) | _ |
| Award Criteria (Eligibility Envelope): Supply and Delivery of Product (ii) (Evidence of compliance with the Medical Device supply / EU Authorised Representative requirements as outlined in the Contract Scope and Specification) | _ |
| Award Criteria (Eligibility Envelope): Registration on the NHS Evergreen Sustainable Supplier Assessment platform, as outlined in the Contract Scope and Specification) | _ |
| Award Criteria (Technical Envelope): Supply and Delivery of Product (Same Working Day Delivery) | 5.0 |
| Award Criteria (Technical Envelope): Supply and Delivery of Product (Wholesale Distribution) | 5.0 |
| Award Criteria (Technical Envelope): Continuity of Supply (Minimum Committed Stockholding) | 8.0 |
| Award Criteria (Eligibility Envelope): Governance, Quality Control and Risk Pharmaceutical Quality Assessment (PQA) Section 1 | _ |
| Award Criteria (Technical Envelope): Governance, Quality Control and Risk Pharmaceutical Quality Assessment (PQA) Section 2 - Section 6 | 40.0 |
| PRICE | 42.0 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price.
Other Information
The estimated total value of contract (excluding VAT) is GBP 15,967,795.33 to GBP 89,818,848.73. This maximum value in the range takes into consideration and accounts for all available extension provision as outlined in the SS17bc Commercial Conditions of Contract for Supplies Contracts documents and provides for potential growth of up to 50% over the course of the contract. The total value of contract (detailed in section V.2.4)) awarded to each of the contractors indicated in this notice is based on an initial contract period of 24 months. It is important to note that there is available provision to extend this initial contract period in accordance with Section 2 of the SS17bc Commercial Conditions of Contract for Supplies Contracts document
Reference
- FTS 002118-2026